BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J, Prieto J. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18:309-314. [PMID: 8340060 DOI: 10.1002/hep.1840180214] [Cited by in Crossref: 106] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kondo R, Kage M, Ogata T, Nakashima O, Akiba J, Nomura Y, Yano H. Therapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis. J Hepatobiliary Pancreat Sci 2015;22:217-24. [DOI: 10.1002/jhbp.177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Huang Y, Ren D, Gao F, Ding Y, Cheng H, Huang X, Xu X. An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis. Minim Invasive Ther Allied Technol 2021;:1-12. [PMID: 34106805 DOI: 10.1080/13645706.2021.1933535] [Reference Citation Analysis]
3 Taya N, Torimoto Y, Shindo M, Hirai K, Hasebe C, Kohgo Y. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br J Haematol. 2000;110:89-97. [PMID: 10930983 DOI: 10.1046/j.1365-2141.2000.01945.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
4 Hirooka M, Ishida K, Kisaka Y, Uehara T, Watanabe Y, Hiasa Y, Michitaka K, Onji M. Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatol Res. 2008;38:1172-1177. [PMID: 18631253 DOI: 10.1111/j.1872-034x.2008.00389.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
5 Hidaka H, Kokubu S, Nakazawa T, Minamino T, Takada J, Tanaka Y, Okuwaki Y, Watanabe M, Shibuya A, Saigenji K. Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res. 2009;39:772-778. [PMID: 19473438 DOI: 10.1111/j.1872-034x.2009.00508.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Sezai S, Kamisaka K, Ikegami F, Usuki K, Urabe A, Tahara T, Kato T, Miyazaki H. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol. 1998;93:80-82. [PMID: 9448180 DOI: 10.1111/j.1572-0241.1998.080_c.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
7 Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Höcker P, Panzer S. Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 1998;28:755-9. [PMID: 9767375 DOI: 10.1046/j.1365-2362.1998.00348.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
8 Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, Xiong B. Impact of TIPS on Splenic Volume and Thrombocytopenia. AJR Am J Roentgenol 2021;216:698-703. [PMID: 33439047 DOI: 10.2214/AJR.20.22958] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Liu R, Teng XJ, He JF, Xiao SS, Yuan ZB, Li XJ, Gao XS, Zhou BM. Partial splenic embolization using Bletilla striata particles for hypersplenism in cirrhosis: a prospective study. Am J Chin Med. 2011;39:261-269. [PMID: 21476204 DOI: 10.1142/S0192415X11008804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 Cai M, Huang W, Lin C, Li Z, Qian J, Huang M, Zeng Z, Huang J, Shan H, Zhu K. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol 2016;26:370-80. [DOI: 10.1007/s00330-015-3839-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg. 2009;16:749-757. [PMID: 19629372 DOI: 10.1007/s00534-009-0149-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
12 Talwar A, Gabr A, Riaz A, Desai K, Thornburg B, Mouli S, Lewandowski RJ, Salem R. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol 2020; 31: 1118-1131. e6. [PMID: 32014400 DOI: 10.1016/j.jvir.2019.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, Nagao Y, Hayashi J, Hashizume M, Maehara Y. Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. J Gastroenterol Hepatol. 2012;27:286-290. [PMID: 21793908 DOI: 10.1111/j.1440-1746.2011.06870.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
14 Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S, Jiang Z, Shan H. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411-416. [PMID: 19070555 DOI: 10.1016/j.dld.2008.10.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
15 Ikegami T, Shimada M, Imura S. Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008;38:1159-71. [PMID: 18684129 DOI: 10.1111/j.1872-034X.2008.00384.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
16 Iwase K, Higaki J, Yoon H, Mikata S, Miyazaki M, Nishitani A, Hori S, Kamiike W. Splenic Artery Embolization Using Contour Emboli Before Laparoscopic or Laparoscopically Assisted Splenectomy: . Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2002;12:331-6. [DOI: 10.1097/00129689-200210000-00005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
17 Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T, Makuuchi M. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg. 2000;190:446-450. [PMID: 10757382 DOI: 10.1016/s1072-7515(99)00294-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
18 Madoff DC, Denys A, Wallace MJ, Murthy R, Gupta S, Pillsbury EP, Ahrar K, Bessoud B, Hicks ME. Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics. 2005;25 Suppl 1:S191-S211. [PMID: 16227491 DOI: 10.1148/rg.25si055504] [Cited by in Crossref: 167] [Cited by in F6Publishing: 93] [Article Influence: 11.1] [Reference Citation Analysis]
19 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 13.2] [Reference Citation Analysis]
20 Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Takeuchi D. Surgical treatment for liver cancer. Current issues. Dig Surg. 2007;24:120-125. [PMID: 17446706 DOI: 10.1159/000101899] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
21 Sandhu DS, Tharayil VS, Lai JP, Roberts LR. Treatment options for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2008;2:81-92. [PMID: 19072372 DOI: 10.1586/17474124.2.1.81] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
22 Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene. 2006;25:3866-3884. [PMID: 16799628 DOI: 10.1038/sj.onc.1209550] [Cited by in Crossref: 269] [Cited by in F6Publishing: 244] [Article Influence: 17.9] [Reference Citation Analysis]
23 Nio M, Hayashi Y, Sano N, Ishii T, Sasaki H, Ohi R. Long-term efficacy of partial splenic embolization in children. Journal of Pediatric Surgery 2003;38:1760-2. [DOI: 10.1016/j.jpedsurg.2003.08.050] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
24 Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-hoz F, Sánchez J, Gil-grande L, Nuño J, Fortún J, Rodriguez-sagrado MA, Moreno A. Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome: Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients. Clinical Transplantation 2010;24:366-74. [DOI: 10.1111/j.1399-0012.2009.01081.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ohira M, Ishifuro M, Ide K, Irei T, Tashiro H, Itamoto T, Ito K, Chayama K, Asahara T, Ohdan H. Significant correlation between spleen volume and thrombocytopenia in liver transplant patients: a concept for predicting persistent thrombocytopenia. Liver Transpl. 2009;15:208-215. [PMID: 19177451 DOI: 10.1002/lt.21663] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
26 Ikezawa K, Naito M, Yumiba T, Iwahashi K, Onishi Y, Kita H, Nishio A, Kanno T, Matsuura T, Ono A. Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. J Viral Hepat. 2010;17:488-492. [PMID: 19840366 DOI: 10.1111/j.1365-2893.2009.01211.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
27 Gonsalves CF, Mitchell EP, Brown DB. Management of Hypersplenism by Partial Splenic Embolization With Ethylene Vinyl Alcohol Copolymer. American Journal of Roentgenology 2010;195:1241-4. [DOI: 10.2214/ajr.10.4401] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Campbell R, Marik PE. Severe autoimmune hemolytic anemia treated by paralysis, induced hypothermia, and splenic embolization. Chest 2005;127:678-81. [PMID: 15706015 DOI: 10.1378/chest.127.2.678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Zhu J, Chen X, Hu X, Zhu H, He C. A Comparative Study of Surgical Splenectomy, Partial Splenic Embolization, and High-Intensity Focused Ultrasound for Hypersplenism. J Ultrasound Med. 2016;35:467-474. [PMID: 26839374 DOI: 10.7863/ultra.15.03050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Helaly AZ, Al-Warraky MS, El-Azab GI, Kohla MA, Abdelaal EE. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism. APMIS 2015;123:1032-9. [PMID: 26547369 DOI: 10.1111/apm.12470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
31 Herrero JI, Sangro B, Quiroga J, Bilbao JI, Yuste JR, Longo J, Pardo F, Hernandez JL, Cienfuegos JA, Prieto J. PARTIAL SPLENIC EMBOLIZATION IN THE TREATMENT OF THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION: . Transplantation 1997;63:482-4. [DOI: 10.1097/00007890-199702150-00029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
32 Katsumori T, Kasahara T. The size of gelatin sponge particles: differences with preparation method. Cardiovasc Intervent Radiol 2006;29:1077-83. [PMID: 16967213 DOI: 10.1007/s00270-006-0059-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
33 Ahuja C, Farsad K, Chadha M. An Overview of Splenic Embolization. AJR Am J Roentgenol 2015;205:720-5. [PMID: 26397320 DOI: 10.2214/AJR.15.14637] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
34 Patel A, Weintraub JL, Nowakowski FS, Kim E, Fischman AM, Ellozy SH, Faries PL, Vouyouka AG, Marin ML, Lookstein RA. Single-center experience with elective transcatheter coil embolization of splenic artery aneurysms: technique and midterm follow-up. J Vasc Interv Radiol. 2012;23:893-899. [PMID: 22579853 DOI: 10.1016/j.jvir.2012.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
35 Beji H, De La Fouchardière C, Desseigne F, Thiesse P, Richioud B, Pilleul F. Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatment. Diagn Interv Imaging 2015;96:383-6. [PMID: 25737395 DOI: 10.1016/j.diii.2014.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Koizumi J, Itou C, Wray R, Myojin K, Hashimoto T, Nagata Y, Yamamuro H, Tsuji T, Ichikawa T, Shiraishi K, Kagawa T, Mine T, Watanabe N, Matsumae M, d’Othée BJ. Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging. Eur Radiol 2013;23:1429-42. [DOI: 10.1007/s00330-012-2711-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Barney EJ, Little EC, Gerkin RD, Ramos AX, Kahn J, Wong M, Kolli G, Manch R. Coated Transjugular Intrahepatic Portosystemic Shunt Does Not Improve Thrombocytopenia in Patients with Liver Cirrhosis. Dig Dis Sci 2012;57:2430-7. [DOI: 10.1007/s10620-012-2162-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
38 Giannini EG, Savarino V. Thrombocytopenia in liver disease: . Current Opinion in Hematology 2008;15:473-80. [DOI: 10.1097/moh.0b013e32830a9746] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
39 Hayashi PH, Mehia C, Joachim Reimers H, Solomon HS, Bacon BR. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis. J Clin Gastroenterol. 2006;40:740-744. [PMID: 16940889 DOI: 10.1097/00004836-200609000-00015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
40 Gu JJ, He XH, Li WT, Ji J, Peng WJ, Li GD, Wang SP, Xu LC. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012;53:862-867. [PMID: 22855417 DOI: 10.1258/ar.2012.110639] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
41 Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:5-11. [PMID: 17958514 DOI: 10.1111/j.1365-2036.2007.03510.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
42 Duan YQ, Gao YY, Ni XX, Wang Y, Feng L, Liang P. Changes in peripheral lymphocyte subsets in patients after partial microwave ablation of the spleen for secondary splenomegaly and hypersplenism: a preliminary study. Int J Hyperthermia 2007;23:467-72. [PMID: 17701538 DOI: 10.1080/02656730701474533] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
43 N’Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, Grando-Lemaire V, Ganne-Carrie N, Sellier N, Trinchet JC. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179-184. [PMID: 15674095 DOI: 10.1097/00042737-200502000-00008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
44 Trotter JF. Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 2006;10:665-78. [DOI: 10.1016/j.cld.2006.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
45 Alonso EM, Hackworth C, Whitington PF. PORTAL HYPERTENSION IN CHILDREN. Clinics in Liver Disease 1997;1:201-22. [DOI: 10.1016/s1089-3261(05)70264-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Elmonem SA, Tantawy HI, Ragheb AS, Matar NE, Tantawi I. The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients. The Egyptian Journal of Radiology and Nuclear Medicine 2011;42:35-42. [DOI: 10.1016/j.ejrnm.2011.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
47 Kimura F, Ito H, Shimizu H, Togawa A, Otsuka M, Yoshidome H, Shimamura F, Kato A, Nukui Y, Ambiru S. Partial splenic embolization for the treatment of hereditary spherocytosis. AJR Am J Roentgenol. 2003;181:1021-1024. [PMID: 14500222 DOI: 10.2214/ajr.181.4.1811021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
48 Akiyama S, Kodera Y, Sekiguchi H, Kasai Y, Kondo K, Ito K, Takagi H. Preoperative embolization therapy for esophageal operation. J Surg Oncol 1998;69:219-23. [DOI: 10.1002/(sici)1096-9098(199812)69:4<219::aid-jso5>3.0.co;2-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
49 Kauffman CR, Mahvash A, Kopetz S, Wolff RA, Ensor J, Wallace MJ. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer. 2008;112:2283-2288. [PMID: 18344210 DOI: 10.1002/cncr.23432] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
50 Chao CP, Nguyen JH, Paz-Fumagalli R, Dougherty MK, Stockland AH. Splenic embolization in liver transplant recipients: early outcomes. Transplant Proc. 2007;39:3194-3198. [PMID: 18089351 DOI: 10.1016/j.transproceed.2007.07.089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
51 Waguri N, Hayashi M, Yokoo T, Sato R, Arao Y, Setsu T, Sato M, Kohisa J, Hama I, Ohsugi K, Aiba T, Yoneyama O, Furukawa K, Sugimura K, Igarashi K, Suda T. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts. J Vasc Interv Radiol. 2012;23:650-657. [PMID: 22459878 DOI: 10.1016/j.jvir.2012.01.065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
52 Rutherford CJ, Frenkel EP. Thrombocytopenia: Issues in Diagnosis and Therapy. Medical Clinics of North America 1994;78:555-75. [DOI: 10.1016/s0025-7125(16)30147-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
53 Pålsson B, Verbaan H. Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2005;17:1153-5. [PMID: 16215425 DOI: 10.1097/00042737-200511000-00001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
54 Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature. J Vasc Interv Radiol. 2007;18:463-481. [PMID: 17446537 DOI: 10.1016/j.jvir.2006.12.734] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
55 Foruny JR, Blázquez J, Moreno A, Bárcena R, Gil-Grande L, Quereda C, Pérez-Elías MJ, Moreno J, Sánchez J, Muriel A. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol. 2005;17:1157-1164. [PMID: 16215426 DOI: 10.1097/00042737-200511000-00002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
56 Bárcena R, Gil-Grande L, Moreno J, Foruny JR, Otón E, García M, Blázquez J, Sánchez J, Moreno A, Moreno A. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005;79:1634-5. [PMID: 15940057 DOI: 10.1097/01.tp.0000155424.52939.3d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
57 Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744-750. [PMID: 18412294 DOI: 10.1002/bjs.6081] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
58 Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22:1682-1688. [PMID: 7489974 DOI: 10.1002/hep.1840220611] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
59 Pandey UC, Jussa ZM, Qureshi IM, Al-dhohayan A, Shareef ZA. Partial Splenic Embolization for the Treatment of Hypersplenism in Tropical Splenomegaly. Trop Doct 1997;27:114-5. [DOI: 10.1177/004947559702700228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Zhu K, Meng X, Li Z, Huang M, Guan S, Jiang Z, Shan H. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol. 2008;66:100-106. [PMID: 17532166 DOI: 10.1016/j.ejrad.2007.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
61 Akiyama S, Ito S, Sekiguchi H, Fujiwara M, Sakamoto J, Kondo K, Kasai Y, Ito K, Takagi H. Preoperative embolization of gastric arteries for esophageal cancer. Surgery 1996;120:542-6. [DOI: 10.1016/s0039-6060(96)80075-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
62 Pillai AK, Andring B, Patel A, Trimmer C, Kalva SP. Portal hypertension: a review of portosystemic collateral pathways and endovascular interventions. Clin Radiol. 2015;70:1047-1059. [PMID: 26188844 DOI: 10.1016/j.crad.2015.06.077] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
63 Amin MA, El Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients. World J Surg 2009;33:1702-10. [DOI: 10.1007/s00268-009-0095-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]